GT Biopharma
GTBP
GTBP
53 hedge funds and large institutions have $32.1M invested in GT Biopharma in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+4
Holders Change %
+8.16%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
14
Reduced
17
Closed
10
Calls
$553K
Puts
$925K
Net Calls
-$372K
Net Calls Change
-$381K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$1.7M |
| 2 |
2
Two Sigma Investments
New York
|
$1.1M |
| 3 |
3
D.E. Shaw & Co
New York
|
$848K |
| 4 |
4
State Street
Boston,
Massachusetts
|
$3.16M |
| 5 |
5
Renaissance Technologies
New York
|
$571K |
